TherapeuticsMD Q2 EPS $(0.24) Misses $(0.07) Estimate, Sales From Cont Ops $400.00K Miss $500.00K Estimate
TherapeuticsMD Q2 EPS $(0.24) Misses $(0.07) Estimate, Sales From Cont Ops $400.00K Miss $500.00K Estimate
TherapeticsMD 第二季度每股收益 (0.24) 低于预期 (0.07) 美元，Cont Ops 的销售额为 400.00 万美元未达预期 50.00 万美元
TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.07) by 242.86 percent. This is a 93.02 percent increase over losses of $(3.44) per share from the same period last year. The company reported quarterly sales of $400.00 thousand which missed the analyst consensus estimate of $500.00 thousand by 20.00 percent.
TherapeicsMD（纳斯达克股票代码：TXMD）公布季度每股亏损0.24美元，比分析师共识估计的0.07美元（0.07美元）低242.86％。这比去年同期每股亏损3.44美元（3.44美元）增长了93.02％。该公司公布的季度销售额为40.00万美元，比分析师共识估计的50.00万美元低20.00％。